The development of biodrugs and biotherapeutics has revolutionized modern medicine, offering targeted treatments for a wide range of diseases, including cancer, autoimmune disorders, and genetic conditions. Biodrugs, which are derived from living organisms, include monoclonal antibodies, vaccines, and recombinant proteins, all designed to interact with specific molecular targets in the body. These biotherapeutic agents offer highly effective treatment options, often with fewer side effects compared to traditional small molecule drugs. The production of biodrugs requires advanced biotechnological processes, such as cell culture and genetic engineering, to ensure that the products are both safe and effective. As research advances, the scope of biotherapeutics continues to expand, with innovations in gene therapy, cell-based therapies, and personalized medicine paving the way for more effective and individualized treatments. The growing field of biodrugs and biotherapeutics holds immense promise for improving patient outcomes and transforming healthcare.
Consolato M Sergi
Universities of Alberta and Ottawa, Canada
Vladlen Slepak
University of Miami Miller School of Medicine, United States
Andreas M Papas
Antares Health Products, United States
Sergey Suchkov
The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian FederationSubmit your abstract Today
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G Protein-Coupled Receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Emerging formulation and delivery applications of Vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, The Russian University of Medicine and Russian Academy of Natural Science-Moscow, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad Autónoma de Baja California, Mexico
Title : Macitentan/Tadalafil Combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Drug development - Importance, trends and digital transformation
Gurpreet Singh, IQVIA, United Kingdom
Title : Navigating the regulatory landscape for nanotechnology-based pharmaceuticals: challenges and strategies for harmonization
Srividya Narayanan, Northeastern University, United States